FrancophonIA/ELRC3.0 huggingface dataset:
English: Infections and infestations Not known: nasopharyngitis
Slovenian: Bolezni kože in podkožja Neznana: urtikarija
English: 3, meibomianitis diplopia
Slovenian: Meibomovih žlez 3, diplopija
English: • Gastric: nausea, vomiting, diarrhoea, intestinal gas or abdominal discomfort, inflammation of the throat, dry or abnormal sensation in mouth, indigestion, stomach ache.
Slovenian: • Želodec: slabost, bruhanje, driska, vetrovi in napenjanje ali neprijeten občutek v trebuhu, vnetje žrela, suh ali nenormalen občutek v ustih, slaba prebava, želodčne bolečine.
English: Gastrointestinal, nervous system, haematological, renal and metabolic effects are generally associated with systemic carbonic anhydrase inhibitors.
Slovenian: Uporaba sistemskih zaviralcev karboanhidraze je običajno združena s pojavom učinkov na prebavila, živčevje, kri, ledvice in presnovo.
English: 3, visual impairment
Slovenian: 3, motnje vida
English: 1, eye pruritus 1, foreign body sensation in eyes 1, ocular hyperaemia
Slovenian: 1, prisotno obarvanje roženice z vitalnim barvilom1, izcedek iz očesa1, očesni pruritus1, občutek tujka v očeh
English: 3, angina pectoris
Slovenian: 2, atrioventrikularni blok 2, kardiorespiratorna striska angina pektoris
English: • Gently press on the base of the bottle to release one drop of AZARGA at a time.
Slovenian: • Nežno pritisnite na dno kapalnega vsebnika, da bo vsakokrat pritekla po ena kapljica zdravila
English: Ear and labyrinth disorders Not known: vertigo
Slovenian: Neznana: vertigo
English: Uncommon: white blood cell count decreased Not known: decreased red blood cell count
Slovenian: Občasni: zmanjšano število levkocitov Neznana: zmanjšano število eritrocitov
English: Potentiated systemic beta-blockade (e.g. decreased heart rate, depression) has been reported during combined treatment with CYP2D6 inhibitors (e.g. quinidine, fluoxetine, paroxetine) and timolol.
Slovenian: Pri sočasnem zdravljenju s timololom in zaviralci izoencima CYP2D6 (npr. kinidinom, fluoksetinom, paroksetinom) so poročali o okrepljeni sistemski beta blokadi (npr. zmanjšani srčni frekvenci in depresiji).
English: 3, back pain
Slovenian: 3, bolečine v hrbtu bolečine v udih
English: 3, pollakiuria
Slovenian: 3, draženje žrela
English: • Bring the bottle tip close to the eye. Use the mirror if it helps.
Slovenian: Če vam pomaga, uporabite ogledalo.
English: There is a potential for an additive effect on the known systemic effects of carbonic anhydrase inhibition in patients receiving an oral carbonic anhydrase inhibitor and brinzolamide eye drops.
Slovenian: Pri bolnikih, ki jemljejo peroralni zaviralec karboanhidraze skupaj z brinzolamid kapljicami za oko, obstaja nevarnost za aditivno delovanje z znanimi sistemskimi učinki zaviralcev karboanhidraze.
English: 3, madarosis
Slovenian: 3, kihanje
English: This may result in a decrease in systemic side effects and an increase in local activity (see section 4.4).
Slovenian: Z zaprtjem nazolakrimalnega kanala ali vek bolnik zmanjša sistemsko absorpcijo zdravila, kar lahko vodi tudi do zmanjšanja njegovih sistemskih neželenih učinkov in do močnejšega lokalnega delovanja (glejte poglavje 4.4).
English: • tell your doctor before you have an operation that you are using AZARGA as timolol may change effects of some medicines used during anaesthesia.
Slovenian: ker timolol lahko spremeni učinke nekaterih zdravil, uporabljenih med anestezijo.
English: 1, abdominal pain diarrhoea 1, dry mouth
Slovenian: 1, bolečine v trebuhu2, diareja1, suha usta1, navzea1, ezofagitis3, dispepsija2,3, neprijeten občutek v trebuhu
English: • Shake well before use.
Slovenian: • Pred uporabo dobro pretresite kapalni vsebnik.
English: There is potential for an additive effect on the known systemic effects of carbonic anhydrase inhibition in patients receiving an oral carbonic anhydrase inhibitor and AZARGA.
Slovenian: Pri bolnikih, ki jemljejo peroralni zaviralec karboanhidraze skupaj z zdravilom AZARGA, obstaja nevarnost za aditivno delovanje z znanimi sistemskimi učinki zaviralcev karboanhidraze.
English: 1, photophobia lacrimation increased 1, scleral hyperaemia
Slovenian: 3, zvišan krvni tlak 1, Raynaudov fenomen
English: 3, depressed mood decreased libido
Slovenian: 3, depresivno razpoloženje
English: Careful monitoring of patients with compromised corneas, such as patients with diabetes mellitus or corneal dystrophies, is recommended.
Slovenian: Tudi pri drugih bolnikih z okvaro roženice, npr. pri tistih s sladkorno boleznijo ali distrofijo roženice, priporočamo skrbno spremljanje bolnika.
English: 1, eye irritation Uncommon: keratitis
Slovenian: 1, očesna bolečina draženje očesa Občasni: keratitis
English: The same types of adverse reactions that are attributable to sulphonamides may occur with topical administration.
Slovenian: Pri njegovi topikalni uporabi se lahko pojavijo enake vrste neželenih učinkov, kot se pojavljajo pri sulfonamidih.
English: 3, scleral pigmentation subconjunctival cyst 3, visual disturbance
Slovenian: 3, občutek vznemirjenosti razdražljivost3, periferni edem3, vidni ostanki zdravila3
English: 3, generalised pruritus skin tightness 3, dermatitis
Slovenian: 3, bolezen očesnih vek 3, edem očesnih vek 1, ptoza
English: 3, increased heart rate chest pain oedema
Slovenian: 3, bolečine v prsih edem2
English: 3, epistaxis bronchial hyperactivity
Slovenian: 1, hiperemija beločnice
English: 3, amnesia 3, memory impairment
Slovenian: 3, amnezija
English: , glare 3, photopsia
Slovenian: 3, fotopsija
English: 3, eyelid oedema
Slovenian: 3, agevzija
English: 1, urticaria 2, pruritus
Slovenian: 3, generalizirani pruritus
English: 3, paraesthesia
Slovenian: 3, parestezija tremor
English: 3, keratoconjunctivitis sicca 3, hypoaesthesia of the eye
Slovenian: 3, hipoestezija očesa
English: Ocular effects
Slovenian: Učinki na oko
English: 3, increased intraocular pressure
Slovenian: 1, povečano solzenje
English: 3, eye swelling
Slovenian: 3, suh nos
English: 1, erythema of eyelid eyelid margin crusting Not known: increased optic nerve cup/disc ratio
Slovenian: Neznana: povečano razmerje med jamico in diskusom vidnega živca
English: 2, anaphylactic shock
Slovenian: 1, prevelika bronhialna reaktivost
English: The non-inferiority of AZARGA as compared to dorzolamide 20 mg/ml + timolol 5 mg/ml in the mean IOP reduction was demonstrated across all time-points at all visits.
Slovenian: Pri vseh obiskih bolnikov so v vseh časovnih točkah dokazali, da kar zadeva srednjo vrednost znižanja očesnega tlaka, zdravilo AZARGA ni slabše od dorzolamida v odmerku 20 mg/ml s timololom v odmerku 5 mg/ml.
English: 2, cardiac failure
Slovenian: 2, srčno popuščanje
English: The European Commission issued a decision on 1 October 2009.
Slovenian: Evropska komisija je odločbo izdala 1. oktobra 2009.
English: Ref. EMEA/CHMP/660222/2009 EMEA/H/A-30/999
Slovenian: EMEA/CHMP/706052/2009 EMEA/H/A-30/999
English: London, 14 October 2009 Doc.
Slovenian: London, 14. oktobra 2009 Sklic dok.
English: Article 30 of Directive 2001/83/EC as amended, referral on the grounds of divergent decisions adopted by Member States
Slovenian: 1 Člen 30 Direktive 2001/83/ES, kakor je bila spremenjena, napotitev zaradi različnih odločitev, ki so jih sprejele države članice.
English: The review was carried out under an ‘Article 30' referral1.
Slovenian: Pregled je bil izveden v skladu z napotitvenim postopkom1 iz člena 30.
English: Migraine
Slovenian: Migrena
English: The CHMP had considered all available evidence and the various indications already authorised in different Member States.
Slovenian: CHMP je upošteval vse razpoložljive dokaze in različne indikacije, ki so že odobrene v posameznih državah članicah.
English: • in adults for the prophylaxis of migraine headache after careful evaluation of possible alternative treatment options.
Slovenian: • pri odraslih bolnikih za profilakso migrenskega glavobola po natančnem vrednotenju mogočih alternativnih možnosti zdravljenja.
English: It is available as tablets (25 mg, 50 mg, 100 mg and 200 mg) and capsules (15 mg, 25 mg and 50 mg).
Slovenian: Na voljo je v obliki tablet (25 mg, 50 mg, 100 mg in 200 mg) in kapsul (15 mg, 25 mg in 50 mg).
English: Topiramate is not intended for acute treatment.'
Slovenian: Topiramat ni namenjen akutnemu zdravljenju.”
English: The company that markets Topamax is Johnson & Johnson Pharma R & D.
Slovenian: Družba, ki zdravilo trži, je Johnson & Johnson Pharma R & D.
English: The CHMP agreed on a harmonised wording for the indications:
Slovenian: CHMP je odobril usklajeno besedilo indikacij:
English: Topamax is also available in the EU under other trade names: Topimax, Epitomax, Topiramat-Cilag, Topiramat-Janssen, Topamax Migräne and Topamac.
Slovenian: Zdravilo Topamax je v EU na voljo tudi pod drugimi imeni: Topimax, Epitomax, Topiramat-Cilag, Topiramat-Janssen, Topamax Migräne in Topamac.
English: Because these cells are involved in causing seizures and in migraines, reducing their electrical activity helps to reduce the chance of having a seizure or developing a migraine.
Slovenian: Ker te celice sodelujejo pri napadih in pri migrenah, zmanjšanje njihove električne aktivnosti pripomore k zmanjšanju možnosti napada ali migrene.
English: Why was Topamax reviewed?
Slovenian: Zakaj je bilo zdravilo Topamax pregledano?
English: It is used as monotherapy (on its own) or as adjunctive therapy (together with other medicines) to prevent seizures (epileptic fits).
Slovenian: Uporablja se za monoterapijo (samostojno) ali dodatno terapijo (skupaj z drugimi zdravili) za preprečevanje epileptičnih napadov.
English: Topamax and associated names have been authorised in the EU via national procedures.
Slovenian: Zdravilo Topamax in z njim povezana imena so v EU odobreni z nacionalnimi postopki.
English: The CHMP harmonised the SPC section on special warnings and included warnings about mood disturbances and depression, suicide and suicidal ideation, and metabolic acidosis (increased acid levels in the body).
Slovenian: CHMP je uskladil poglavje povzetka glavnih značilnosti zdravila o posebnih opozorilih ter dodal opozorila o spremembah razpoloženja in depresiji, samomoru in samomorilnem razmišljanju ter presnovni acidozi (zvišanih ravneh kisline v telesu).
English: Topamax is also used to prevent migraine headaches.
Slovenian: Zdravilo Topamax se uporablja tudi za preprečevanje migrenskih glavobolov.
English: The initial dose should be of 25 mg a day for one week followed by weekly increases of 25 mg until a beneficial dose is reached.
Slovenian: Začetni odmerek je 25 mg na dan in se ga jemlje en teden, temu pa sledijo tedenska povečanja odmerka za 25 mg, dokler se ne doseže odmerek s koristnim učinkom.
English: Topamax is an antiepileptic medicine.
Slovenian: Topamax je zdravilo proti epilepsiji.
English: The exact way in which topiramate, the active substance in Topamax, works is unknown but it is thought to act by interfering with the activity of receptors on nerve cells, which leads to a reduction in electrical transmission.
Slovenian: Natančen način delovanja topiramata, zdravilne učinkovine v zdravilu Topamax, ni znan, vendar naj bi motil aktivnost receptorjev na živčnih celicah in s tem povzročil manjši prenos električnega toka.
English: Questions and answers on the referral for Topamax and associated names topiramate tablets and capsules
Slovenian: Vprašanja in odgovori v zvezi z napotitvenim postopkom za zdravilo Topamax in z njim povezana imena topiramat, tablete in kapsule
English: The European Medicines Agency has completed a review of Topamax and associated names.
Slovenian: Evropska agencija za zdravila je zaključila pregled zdravila Topamax in z njim povezanih imen.
English: The Committee did not include a contraindication for the use of Topamax for treating epilepsy in pregnant women or women of childbearing potential who are not using effective methods of contraception.
Slovenian: Odbor ni vključil kontraindikacije za uporabo zdravila Topamax pri zdravljenju epilepsije pri nosečnicah in ženskah v rodni dobi, ki ne uporabljajo učinkovitih postopkov kontracepcije.
English: The CHMP, in the light of the data submitted and the scientific discussion within the Committee, was of the opinion that the SPCs, labelling and package leaflets should be harmonised across the EU.
Slovenian: CHMP je ob upoštevanju predloženih podatkov in znanstvenih razprav v okviru Odbora menil, da je treba povzetke glavnih značilnosti zdravila, označevanje in navodila za uporabo uskladiti v celotni EU.
English: The main differences concerned the age of children that can be given Topamax, and the medicine's use in monotherapy and conversion to monotherapy.
Slovenian: Glavne razlike so se nanašale na starost otrok, ki lahko prejmejo zdravilo Topamax, ter na uporabo tega zdravila v monoterapiji in prehod na monoterapijo.
English: • ‘monotherapy in adults, adolescents and children over six years of age with partial seizures with or without secondary generalised seizures, and primary generalised tonic-clonic seizures;
Slovenian: • „monoterapija pri odraslih bolnikih, mladostnikih in otrocih, starejših od 6 let, s parcialnimi napadi s sekundarno generalizacijo ali brez nje in primarno generaliziranimi tonično-kloničnimi napadi,
English: The CHMP removed a restriction that was present in some Member States that Topamax monotherapy be used for only newly diagnosed epilepsy.
Slovenian: CHMP je ukinil omejitev v določenih državah članicah, ki je določala, da se monoterapija z zdravilom Topamax uporablja le pri bolnikih, ki imajo na novo diagnosticirano epilepsijo.
English: The new wording highlights the possibility of reduced effectiveness of oral contraceptives in patients taking Topamax.
Slovenian: Novo besedilo poudarja možnost zmanjšane učinkovitosti peroralnih kontracepcijskih sredstev pri bolnicah, ki jemljejo zdravilo Topamax.
English: What is Topamax?
Slovenian: Kaj je zdravilo Topamax?
English: • adjunctive therapy in children aged 2 years and above, adolescents and adults for partial onset seizures with or without secondary generalization or primary generalized tonic-clonic seizures and for the treatment of seizures associated with Lennox-Gastaut syndrome;
Slovenian: • „dodatna terapija pri otrocih, starih 2 leti ali več, mladostnikih in odraslih bolnikih z napadi parcialnega izvora s sekundarno generalizacijo ali brez nje ali primarno generaliziranimi tonično-kloničnimi napadi in za zdravljenje napadov, povezanih z Lennox-Gastautovim sindromom,
English: The Committee also harmonised the SPC section on the interactions of Topamax with other medicines.
Slovenian: Odbor je uskladil tudi poglavje povzetka glavnih značilnosti zdravila o medsebojnem delovanju zdravila Topamax z drugimi zdravili.
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) has concluded that there is a need to harmonise the prescribing information for Topamax and associated names in the European Union (EU) and the European Economic Area (EEA).
Slovenian: Odbor za zdravila za uporabo v humani medicini (CHMP) pri Agenciji je zaključil, da je treba v Evropski uniji (EU) in v Evropskem gospodarskem prostoru (EGP) uskladiti podatke o predpisovanju zdravila Topamax in z njim povezanih imen.
English: This has led to divergences across Member States in the way the medicine can be used, as seen in the differences in the Summaries of Product Characteristics (SPCs), labelling and package leaflets in the different countries where the product is marketed.
Slovenian: To je v različnih državah članicah, kjer je zdravilo na tržišču, privedlo do razhajanj glede uporabe zdravila, kot je razvidno iz povzetkov glavnih značilnosti zdravila, označevanja in navodil za uporabo.
English: The Committee also recommended the initial dose of 100 mg in children aged six years and above.
Slovenian: Odbor je za otroke, starejše od 6 let, priporočil začetni odmerek 100 mg.
English: For children aged two years and above, the Committee recommended a dose of 5 to 9 mg per kilogram body weight a day, divided into two doses.
Slovenian: Za otroke, stare 2 leti ali več, je Odbor priporočil odmerek od 5 do 9 mg na kilogram telesne mase na dan, razdeljen na dva odmerka.
English: For monotherapy in adults the CHMP recommended 100 mg to 200 mg a day as the initial dose and a maximum daily dose of 500 mg a day, divided into two doses.
Slovenian: CHMP je za monoterapijo pri odraslih bolnikih priporočil začetni odmerek od 100 mg do 200 mg na dan in največji dnevni odmerek 500 mg na dan, razdeljen na dva odmerka.
English: For prevention of migraine in adults, the Committee recommended a total daily dose of 100 mg, divided into two doses.
Slovenian: Za preprečevanje migrene pri odraslih bolnikih je Odbor priporočil skupni dnevni odmerek 100 mg, razdeljen na dva odmerka.
English: On 8 May 2008, the European Commission referred the matter to the CHMP in order to harmonise the marketing authorisations for Topamax and associated names in the EU and the EEA.
Slovenian: Da bi Evropska komisija uskladila dovoljenja za promet z zdravilom Topamax in z njim povezanimi imeni v EU in EGP, je dne 8. maja 2008 zadevo napotila na CHMP.
English: For adjunctive therapy, the Committee endorsed a dose range for adults of 200 to 400 mg a day, divided into two doses.
Slovenian: Za dodatno terapijo pri odraslih bolnikih je Odbor odobril razpon odmerkov od 200 do 400 mg na dan, razdeljenih na dva odmerka.
English: Topamax has been identified as needing harmonisation by the Co-ordination Group on the Mutual Recognition and Decentralised Procedures - Human (CMD(h)).
Slovenian: Usklajevalna skupina za postopek medsebojnega priznavanja in decentralizirane postopke za zdravila za uporabo v humani medicini (CMD(h)) je ugotovila, da je za zdravilo Topamax potrebno usklajevanje.
English: Advice was included in section 4.6 of the SPC about the risks to the mother and the unborn baby of treatment with Topamax.
Slovenian: Opozorilo o tveganju uporabe zdravila Topamax za mater in nerojenega otroka je bilo vključeno v poglavje 4.6 povzetka glavnih značilnosti zdravila.
English: Patients who may be hypersensitive (allergic) to the active substance or to any of the other ingredients should not take Topamax.
Slovenian: CHMP je odobril tudi usklajeno besedilo kontraindikacij: Zdravila Topamax ne smejo jemati bolniki, ki utegnejo biti preobčutljivi za (alergični na) zdravilno učinkovino ali katerokoli drugo sestavino zdravila.
English: It is used in patients who have not been treated for this disease before.
Slovenian: Uporablja se pri bolnikih, ki se še niso zdravili zaradi te bolezni.
English: In all studies, the main measure of effectiveness was the number of patients with a complete or partial response to treatment.
Slovenian: V vseh raziskavah je bilo glavno merilo učinkovitosti število bolnikov s popolnim ali delnim odzivom na zdravljenje.
English: After 14 days of treatment, both medicines had been successful in curing or improving about 92% of patients.
Slovenian: Po 14 dneh zdravljenja sta bili obe zdravili uspešni pri ozdravljenju ali izboljšanju stanja 92 % bolnikov.
English: The duration of treatment depends on the patient's condition.
Slovenian: Trajanje zdravljenja je odvisno od bolnikovega stanja.
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the studies performed, to reach their recommendations on how to use the medicine.
Slovenian: Pojasnjuje, kako je Odbor za zdravila za uporabo v humani medicini (CHMP) ocenil opravljene raziskave, na podlagi česar je oblikoval priporočila glede uporabe zdravila.
English: The most commonly reported side effects are nausea (feeling sick, 6%) and headache (6%).
Slovenian: Najpogostejša neželena učinka, o katerih so poročali, sta navzeja (slabost, 6 %) in glavobol (6 %).
English: The duration of treatment depends on the severity of the disease and the patient's response.
Slovenian: Trajanje zdravljenja je odvisno od resnosti bolezni in bolnikovega odziva.
English: If you need more information about your medical condition or your treatment, read the Package Leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Slovenian: Če potrebujete več informacij o vašem zdravstvenem stanju ali zdravljenju, preberite Navodila za uporabo (ki so prav tako del EPAR) ali se posvetujte s svojim zdravnikom ali farmacevtom.
English: The effectiveness was measured by looking at how many patients developed an invasive fungal infection, either proven or probable, during the studies.
Slovenian: Učinkovitost so merili z opazovanjem, pri koliko bolnikih se je med raziskavami razvila invazivna glivična okužba, dokazana ali verjetna.
English: The European Commission granted a marketing authorisation valid throughout the European Union, for Posaconazole SP to SP Europe on 25 October 2005.
Slovenian: Evropska komisija je dovoljenje za promet z zdravilom Posaconazole SP, veljavno po vsej Evropski uniji, odobrila družbi SP Europe dne 25. oktobra 2005.
English: Other common side effects (seen in between 1 and 10 patients in 100) are neutropenia (low white blood cell count), electrolyte imbalance, anorexia (lack of appetite), dizziness, paresthesia (pins and needles), somnolence (sleepiness), vomiting, abdominal (tummy) pain, diarrhoea, dyspepsia (indigestion), dry mouth, flatulence (gas), signs of liver damage in the blood, rash, asthenia (weakness), fatigue (tiredness) and pyrexia (fever).
Slovenian: Drugi pogosti neželeni učinki (o katerih so poročali pri 1 do 10 izmed 100 bolnikov) so nevtropenija (majhno število belih krvnih celic), neravnovesje elektrolitov, anoreksija (pomanjkanje apetita), omotica, parestezija (mravljinčenje), somnolenca (zaspanost), bruhanje, abdominalne bolečine (bolečine v trebuhu), driska, dispepsija (prebavne motnje), suha usta, flatulenca (vetrovi), znaki jetrne okvare v krvi, izpuščaj, astenija (šibkost), utrujenost in pireksija (povišana telesna temperatura).
English: The oral suspension must be shaken
Slovenian: Pred uporabo je treba peroralno suspenzijo dobro pretresti.
English: EUROPEAN PUBLIC ASSESSMENT REPORT (EPAR) POSACONAZOLE SP EPAR summary for the public
Slovenian: EVROPSKO JAVNO POROČILO O OCENI ZDRAVILA (EPAR) POSACONAZOLE SP Povzetek EPAR za javnost
English: Caution is also needed when Posaconazole SP is taken at the same time as other medicines.
Slovenian: Prav tako je potrebna previdnost pri sočasnem jemanju zdravila Posaconazole SP z drugimi zdravili.
English: Without ergosterol, the fungus is killed or prevented from spreading.
Slovenian: Brez ergosterola glivica odmre, oziroma se ne more širiti.
English: • Simvastatin, lovastatin or atorvastatin (used to lower cholesterol).
Slovenian: • simvastatin, lovastatin ali atorvastatin (ki se uporabljajo za zniževanje holesterola).
English: Posaconazole SP should not be used in patients who are taking any of the following drugs:
Slovenian: Zdravilo Posaconazole SP se ne sme uporabljati pri bolnikih, ki jemljejo katero koli od naslednjih zdravil:
English: It is used to treat patients with the following diseases, when they cannot tolerate other antifungal medicines (amphotericin B, itraconazole or fluconazole) or have not improved after at least 7 days of treatment with other antifungal medicines:
Slovenian: Uporablja se za zdravljenje bolnikov z naslednjimi boleznimi, kadar ne prenašajo drugih antimikotikov (amfotericina B, itrakonazola ali flukonazola) ali kadar se stanje pri njih ni izboljšalo po vsaj 7 dneh zdravljenja z drugimi antimikotiki.
English: Posaconazole SP is used if the disease is severe, or if the patient is immunocompromised (with a weakened immune system).
Slovenian: Zdravilo Posaconazole SP se uporablja, če je bolezen huda ali če je bolnik imunokompromitiran (ima oslabljen imunski sistem).
English: Other information about Posaconazole SP:
Slovenian: Druge informacije o zdravilu Posaconazole SP:
English: • chromoblastomycosis and mycetoma (long-term fungal infections of the skin or the tissue just below the skin, usually caused by fungal spores infecting wounds due to thorns or splinters),
Slovenian: • kromoblastomikoza in micetom (dolgotrajni glivični okužbi kože in podkožnega tkiva, ki ju navadno povzročajo glivične spore, ki okužijo rane, ki jih povzročijo trni ali trske),